ZymoGenetics, Inc. (ZGEN)
$5.92
0.18 (+3.14%)
| CAPS Rating |
|
|---|---|
| Open | $5.74 |
| Previous Close | $5.74 |
| Daily Range | $5.61 - $5.95 |
| 52-Week Range | $2.06 - $6.71 |
| Market Cap | $410.14M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 175,209 |
| Average Daily Volume | 257,000 |
ZGEN
VS S&P 500 (SPY)
How do you think ZGEN will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ZGEN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ZGEN News and Commentary
- BUY OR SELL-Will ZymoGenetics shares start to bleed? – Reuters
- 6 Stocks Losing Top Investor Support – The Motley Fool
- UPDATE 1-Zymogenetics says Merck Serono discontinues MS trials – Reuters
- ZymoGenetics Goes in for the Kill – The Motley Fool
- 5 Cold Stocks Heating Up – The Motley Fool
- It's Just A Flesh Wound – Blog at The Motley Fool
- Parachutes, Cliffs, and Softer Landings – The Motley Fool
- 9 Stocks to Shake the Market – The Motley Fool
- 10 Stocks to Shake the Market – The Motley Fool
- Mark Your Calendars: The Race Is On! – The Motley Fool
- A Mini-Pfizer in the Making – The Motley Fool
- Wall Street's Buy List – The Motley Fool
- ZymoGenetics, the Pharmaceutical Zombie – The Motley Fool
- ZymoGenetics Leads With Its Chin – The Motley Fool
- Small cap biotech investing in the era of underperformance – Blog at The Motley Fool
- Get Ready for the Bounce – The Motley Fool
- King's Unstoppable Urge to Merge – The Motley Fool
- Don't Discard Omrix – The Motley Fool
- Unloved Stocks Ready to Shine – The Motley Fool
- Wounded by a Partner? – The Motley Fool
RSS Headlines
Fool UK
